Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso‐occlusive episodes during the randomized, open‐label HELPS study
British Journal of Haematology（2022）
Key words
clinical trial,hydroxycarbamide,inflammation,sickle cell disease,vaso-occlusive crisis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined